Publication:
Extended regorafenib treatment can be linked with mitochondrial damage leading to cardiotoxicity.

Placeholder

Organizational Units

Program

Authors

Boran, T
Akyildiz, AYŞENUR
Jannuzzi, AT
Alpertunga, B

Advisor

Language

Publisher

Journal Title

Journal ISSN

Volume Title

Abstract

Description

Source:

Keywords:

Keywords

Citation

Boran T., Akyildiz A., Jannuzzi A., Alpertunga B., -Extended regorafenib treatment can be linked with mitochondrial damage leading to cardiotoxicity.-, Toxicology letters, 2020

Endorsement

Review

Supplemented By

Referenced By

0

Views

0

Downloads

View PlumX Details


Sustainable Development Goals

Thumbnail Image
Goal